Metabolic decompensation in pump users due to lispro insulin precipitation
暂无分享,去创建一个
Small, short term studies show that lispro insulin (Humalog; Eli Lilly & Co, Indianapolis, IN), commonly used in pump therapy, is stable in insulin pumps.1 However, in agreement with reports by others,2 we have noted several patients who have developed erratic and unpredictable glucose fluctuations with lispro insulin that have resolved when the treatment was changed to buffered regular insulin (Velosulin; Novo Nordisk, Princeton, NJ) and aspart insulin (Novolog; Novo Nordisk, Princeton, NJ). We have …
[1] A. W. Wright,et al. Cannula Occlusion With Use of Insulin Lispro and Insulin Infusion System , 1998, Diabetes Care.
[2] B. Zinman,et al. Stability of Insulin Lispro in Insulin Infusion Systems , 1997, Diabetes Care.